Physician profile
Sidhartha Chandela
NPI 1033340229
$22,476.34
in general payments reported to CMS, 2019-2025
16 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,821 · 2020: $1,130 · 2021: $1,929 · 2022: $3,012 · 2023: $3,883 · 2024: $7,228 · 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,984.04 |
| Travel and Lodging | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,859.35 | 2019-2025 | N/A, Monterey Al, Vitoss |
| Orthofix Medical, INC. | $1,786.38 | 2019-2025 | Trinity Elite, Alloquent S |
| Teva Pharmaceuticals USA, INC. | $482.92 | 2019-2023 | Austedo Xr |
| Medtronic, INC. | $467.59 | 2021-2024 | Unid_pass |
| Augmedics INC. | $191.14 | 2021 | |
| Abbott Laboratories | $117.34 | 2021 | |
| Depuy Synthes Sales INC. | $108.75 | 2022-2024 | Synthecel, Matrixneuro |
| Boston Scientific Corporation | $105.42 | 2021 | |
| Novo Nordisk INC | $97.48 | 2025 | Wegovy |
| Medtronic USA, INC. | $85.18 | 2019-2020 | |
| Arteriocyte Medical Systems, INC. | $61.97 | 2025 | Magellan |
| Musculoskeletal Transplant Foundation INC. | $38.56 | 2019 | |
| Allergan, INC. | $23.81 | 2020 | |
| Smith+Nephew, INC. | $20.60 | 2019 | |
| Intrinsic Therapeutics | $15.67 | 2023 | Barricaid Acd (Annular Closure Device) |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $14.18 | 2024 | Spinal Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidhartha Chandela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.